IMAST 2020 Abstract Submission Site Closes
November 1, 2019 - 11:59 US Eastern Time
Submit an Abstract
Click here if you've been listed on an abstract and need to disclose
All abstract authors will be required to submit a Financial Disclosure Statement, an FDA Disclosure Form, an Attestation and Non-Exclusive Licensing Agreement during the online submission process. ALL authors listed on an abstract will be required to submit a financial disclosure form, including disclosure of ALL financial relationships, not only those pertaining to the topic of the abstract. In the event that all authors on an abstract have not completed these required forms prior to the submission deadline of November 1, 2019 the abstract will NOT be reviewed or considered for inclusion in the IMAST program.
Submitted abstracts will be reviewed and graded in blinded fashion by the IMAST Committee. The review process takes approximately 8 weeks, and acceptance notification for IMAST will be made via email by December 20, 2019.
|August 1, 2019
|| Abstract Submission Site Opens
|November 1, 2019
|| Abstract Submission Deadline
|December 16, 2019
|| IMAST Abstract Notification
|January 15, 2020
|| Deadline to accept presentation in program and register for IMAST
All abstracts must be submitted online by Friday, November 1, 2019. No exceptions will be made.
Abstracts with authors missing completed Conflict of Interest Disclosures will NOT be reviewed.
Abstracts submitted to the 27th IMAST must fit into one of the following categories to be considered for presentation:
- Adolescent Idiopathic Scoliosis
- Adult Spinal Deformity
- Basic Science/Biomechanics/Genetics
- Cervical Deformity
- Cervical Degenerative/ Reconstruction
- Early Onset Scoliosis
- Innovative Methods
- Lumbar Degenerative
- Minimally Invasive Surgery
- Miscellaneous (Spondy, Trauma, Tumor, etc.)
- Motion Preservation
- Neuromuscular/Syndromic Deformity
- Non-Op Treatment Methods